Blood-Based Oxidation Markers in Medicated and Unmedicated Schizophrenia Patients: A Meta-Analysis

Bias in meta-analysis detected by a simple, graphical test

Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722 · see citing works

Free radicals and antioxidants in normal physiological functions and human disease

Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T. D., Mazur, M., & Telser, J. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.07.001 · Cited by 14,269 · see citing works

Trim and Fill: A Simple Funnel‐Plot–Based Method of Testing and Adjusting for Publication Bias in Meta‐Analysis

Duval, S., & Tweedie, R. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00455.x · Cited by 14,099 · see citing works

Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range

Wan, X., Wang, W., Liu, J., & Tong, T. (2014) · BMC Medical Research Methodology · doi:10.1186/1471-2288-14-135 · Cited by 11,735 · see citing works

Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.

Ignarro, L. J., Buga, G. M., Wood, K. S., Byrns, R. E., & Chaudhuri, G. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.9265 · Cited by 5,074 · see citing works

Oxidative Stress: Harms and Benefits for Human Health

Pizzino, G., Irrera, N., Cucinotta, M., Pallio, G., Mannino, F., Arcoraci, V., Squadrito, F., Altavilla, D., & Bitto, A. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/8416763 · Cited by 4,837 · see citing works

Assessing heterogeneity in meta-analysis: Q statistic or I² index?

Huedo-Medina, T. B., Sánchez-Meca, J., Marín-Martínez, F., & Botella, J. (2006) · Psychological Methods · doi:10.1037/1082-989x.11.2.193 · Cited by 4,256 · see citing works

Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: Analytical and biological challenges

Tsikas, D. (2017) · Analytical Biochemistry · doi:10.1016/j.ab.2016.10.021 · Cited by 2,190 · see citing works

Free radical-mediated oxidation of free amino acids and amino acid residues in proteins

Stadtman, E. R., & Levine, R. L. (2003) · Amino Acids · doi:10.1007/s00726-003-0011-2 · Cited by 1,968 · see citing works

Role of ROS and RNS Sources in Physiological and Pathological Conditions

Meo, S. D., Reed, T. T., Venditti, P., & Víctor, V. M. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/1245049 · Cited by 1,638 · see citing works

Oxidants in Cigarette Smoke Radicals, Hydrogen Peroxide, Peroxynitrate, and Peroxynitritea

Pryor, W. A., & Stone, K. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb39148.x · Cited by 1,154 · see citing works

Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders

Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090 · see citing works

Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs

Miyamoto, S., Duncan, G. E., Marx, C. E., & Lieberman, J. A. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001556 · Cited by 988 · see citing works

Nitric oxide as modulator of neuronal function

Prast, H., & Philippu, A. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00044-7 · Cited by 937 · see citing works

Oxidative stress in obesity: A critical component in human diseases

Marseglia, L., Manti, S., D’Angelo, G., Nicotera, A., Parisi, E., Di Rosa, G., Gitto, E., & Arrigo, T. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms16010378 · Cited by 933 · see citing works

Publication bias—a problem in interpreting medical data

Begg, C. B., & Berlin, J. A. (1988) · Journal of the Royal Statistical Society. Series A (Statistics in Society) · doi:10.2307/2982993 · Cited by 814 · see citing works

Concordance between administrative claims and registry data for identifying metastasis to the bone: an exploratory analysis in prostate cancer

Onukwugha, E., Yong, C., Hussain, A., Seal, B., & Mullins, C. D. (2014) · BMC Medical Research Methodology · doi:10.1186/1471-2288-14-1 · Cited by 589 · see citing works

Current Concepts and Treatments of Schizophrenia

Stępnicki, P., Kondej, M., & Kaczor, A. A. (2018) · Molecules · doi:10.3390/molecules23082087 · Cited by 570 · see citing works

Meta-analysis of oxidative stress in schizophrenia.

Flatow, J., Buckley, P., & Miller, B. J. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.03.018 · Cited by 491 · see citing works

Approaches and Methods to Measure Oxidative Stress in Clinical Samples: Research Applications in the Cancer Field

Katerji, M., Filippova, M., & Duerksen-Hughes, P. J. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/1279250 · Cited by 435 · see citing works

Adverse effects of antipsychotic medications.

Muench, J., & Hamer, A. M. (2010) · PubMed · Cited by 427 · see citing works

ROS and Brain Diseases: The Good, the Bad, and the Ugly

Popa-Wagner, A., Mitran, S., Sivanesan, S., Chang, E., & Buga, A.-M. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/963520 · Cited by 427 · see citing works

Free radical pathology and antioxidant defense in schizophrenia: a review

Mahadik, S. P., & Mukherjee, S. (1996) · Schizophrenia Research · doi:10.1016/0920-9964(95)00049-6 · Cited by 330 · see citing works

Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics

Khan, M. M. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00334-6 · Cited by 300 · see citing works

The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients

Akyol, Ö., Herken, H., Uz, E., Fadıllıoğlu, E., Ünal, S., Söğüt, S., Özyurt, H., & SAVAS, H. A. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00220-8 · Cited by 278 · see citing works

Oxidative Stress and Inflammation in First-Episode Psychosis: A Systematic Review and Meta-analysis

Fraguas, D., Díaz‐Caneja, C. M., Ayora, M., Hernández-Álvarez, F., Rodríguez-Quiroga, A., Recio, S., Leza, J. C., & Arango, C. (2018) · Schizophrenia Bulletin · doi:10.1093/schbul/sby125 · Cited by 272 · see citing works

Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics

Zhang, X., Tan, Y. L., Cao, L. Y., Wu, G. Y., Xu, Q., Shen, Y., & Zhou, D. F. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.10.011 · Cited by 262 · see citing works

Thinking and acting beyond the positive: the role of the cognitive and negative symptoms in schizophrenia

Carbon, M., & Correll, C. U. (2014) · CNS Spectrums · doi:10.1017/s1092852914000601 · Cited by 258 · see citing works

Oxidative Stress in Schizophrenia

Grabnar, I., Vovk, T., Plesničar, B. K., & Boskovic, M. (2011) · Current Neuropharmacology · doi:10.2174/157015911795596595 · Cited by 250 · see citing works

Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in different phases of bipolar disorder and in schizophrenia

Kunz, M., Gama, C. S., Andreazza, A. C., Salvador, M. M., Ceresér, K. M., Gomes, F. A., Belmonte-de-Abreu, P. S., Berk, M., & Kapczinski, F. P. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.07.001 · Cited by 241 · see citing works

Evidence that the activities of erythrocyte free radical scavenging enzymes and the products of lipid peroxidation are increased in different forms of schizophrenia

Herken, H., Uz, E., Özyurt, H., Söğüt, S., Vırıt, O., & Akyol, Ö. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000789 · Cited by 238 · see citing works

Biochemical and spectrophotometric significance of advanced oxidized protein products

Capeillère‐Blandin, C., Gausson, V., Descamps‐Latscha, B., & Witko‐Sarsat, V. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.02.008 · Cited by 202 · see citing works

BIOMARKERS OF OXIDATIVE STRESS IN RED BLOOD CELLS

Pandey, K. B., & Rizvi, S. I. (2011) · Biomedical Papers · doi:10.5507/bp.2011.027 · Cited by 189 · see citing works

Oxidative stress, prefrontal cortex hypomyelination and cognitive symptoms in schizophrenia

Maas, D. A., Vallès, A., & Martens, G. J. M. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.138 · Cited by 181 · see citing works

The many faces of nitric oxide in schizophrenia. A review

Bernstein, H., Bogerts, B., & Keilhoff, G. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.05.019 · Cited by 179 · see citing works

A meta-analysis of oxidative stress markers in schizophrenia

Zhang, M., Zhao, Z., He, L., & Wan, C. (2010) · Science China Life Sciences · doi:10.1007/s11427-010-0013-8 · Cited by 173 · see citing works

Evaluation of antioxidant enzymes activities and lipid peroxidation in schizophrenic patients treated with typical and atypical antipsychotics

Pădurariu, M., Ciobica, A. S., Dobrin, I., & Ștefănescu, C. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.05.088 · Cited by 171 · see citing works

Superoxide dismutase and catalase activities and their correlation with malondialdehyde in schizophrenic patients

Rukmini, M. S., D’Souza, B., & D’Souza, V. (2004) · Indian Journal of Clinical Biochemistry · doi:10.1007/bf02894268 · Cited by 141 · see citing works

Dopamine System Stabilizers, Aripiprazole, and the Next Generation of Antipsychotics, Part 2: Illustrating Their Mechanism of Action

Stahl, S. M. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n1201 · Cited by 136 · see citing works

Use of Malondialdehyde as a Biomarker for Assessing Oxidative Stress in Different Disease Pathologies: a Review

Singh, Z., Karthigesu, I. P., Singh, P., & Kaur, R. (2014) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 135 · see citing works

Possible Involvement of Free Radicals in Neuroleptic‐Induced Movement Disorders Evidence from Treatment of Tardive Dyskinesia with Vitamin E

Cadet, J. L., & Lohr, J. B. (1989) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1989.tb14918.x · Cited by 135 · see citing works

Erythrocyte Superoxide Dismutase and Glutathione Peroxidase Activities, and Malondialdehyde and Reduced Glutathione Levels in Schizophrenic Patients

Altuntaş, İ., Aksoy, H., Coşkun, İ., Çayköylü, A., & Akçay, F. (2000) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2000.201 · Cited by 131 · see citing works

Biochemistry of Reactive Oxygen and Nitrogen Species

Özcan, A., & ÖĞÜN, M. (2015) · InTech eBooks · doi:10.5772/61193 · Cited by 127 · see citing works

Oxidative Damage and Schizophrenia: The Potential Benefit by Atypical Antipsychotics

Dakhale, G. N., Khanzode, S. D., Khanzode, S. S., Saoji, A., Khobragade, L., & Turankar, A. V. (2004) · Neuropsychobiology · doi:10.1159/000077368 · Cited by 118 · see citing works

Oxidative stress in schizophrenia: a case-control study on the effects on social cognition and neurocognition

Gonzalez-Liencres, C., Taş, C., Brown, E. C., Erdin, S., Onur, E., Çubukcoǧlu, Z., Aydemır, Ö., Esen-Danacı, A., & Brüne, M. (2014) · BMC Psychiatry · doi:10.1186/s12888-014-0268-x · Cited by 118 · see citing works

Altered antioxidant defense system in clinically stable patients with schizophrenia and their unaffected siblings

Othmen, L. B., Mechri, A., Fendri, C., Bost, M., Chazot, G., Gaha, L., & Kerkeni, A. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.08.003 · Cited by 117 · see citing works

Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in schizophrenia: A study of patients treated with haloperidol or clozapine

Gama, C. S., Salvador, M. M., Andreazza, A. C., Kapczinski, F. P., & Belmonte-de-Abreu, P. S. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.11.009 · Cited by 116 · see citing works

Oxidative Stress During Treatment With First- and Second-Generation Antipsychotics

Kropp, S., Kern, V., Lange, K., Degner, D., Hajak, G., Kornhuber, J., Rüther, E., Emrich, H. M., Schneider, U., & Bleich, S. (2005) · Journal of Neuropsychiatry · doi:10.1176/jnp.17.2.227 · Cited by 116 · see citing works

Different sub-anesthetic doses of ketamine increase oxidative stress in the brain of rats

de Oliveira, L., dos Santos, C. M. S., Bortolin, T., Canever, L., Petronilho, F. C., Mina, F., Dal‐Pizzol, F., Quevedo, J., & Zugno, A. I. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.05.010 · Cited by 113 · see citing works

Implication du stress oxydant dans la physiopathologie de la schizophrénie : revue de la literature

Fendri, C., Mechri, A., Khiari, G., Othman, A., Kerkeni, A., & Gaha, L. (2006) · L Encéphale · doi:10.1016/s0013-7006(06)76151-6 · Cited by 109 · see citing works

Mitochondrial activity and oxidative stress markers in peripheral blood mononuclear cells of patients with bipolar disorder, schizophrenia, and healthy subjects

Gubert, C., Stertz, L., Pfaffenseller, B., Panizzutti, B., Rezin, G. T., Massuda, R., STRECK, E. L., Gama, C. S., Kapczinski, F. P., & Kunz, M. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.06.018 · Cited by 108 · see citing works

Relationship between neutrophil/lymphocyte ratio with oxidative stress and psychopathology in patients with schizophrenia

Kulaksızoğlu, B., & Kulaksızoğlu, S. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s110484 · Cited by 108 · see citing works

Haloperidol and clozapine, but not olanzapine, induces oxidative stress in rat brain

Reinke, A., Martins, M. R., de Lima, M. S., Moreira, J. C. F., Dal‐Pizzol, F., & Quevedo, J. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.09.032 · Cited by 107 · see citing works

Predictors of improvement in tardive dyskinesia following discontinuation of neuroleptic medication

Glazer, W. M., Morgenstern, H., Schooler, N., Berkman, C. S., & Moore, D. C. (1990) · British Journal of Psychiatry · doi:10.1192/bjp.157.4.585 · Cited by 106 · see citing works

Characterization of the potential antioxidant and pro-oxidant actions of some neuroleptic drugs

Jeding, I. B., Evans, P., Akanmu, D., Dexter, D. T., Spencer, J. D., Aruoma, O. I., Jenner, P. G., & Halliwell, B. B. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)00424-k · Cited by 104 · see citing works

Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia

Asevedo, E. D. M., Gadelha, A., Noto, C. D. S., Mansur, R. B., Zugman, A., Belangero, S. I., Berberian, A. D. A., Scarpato, B. S., Leclerc, E., Teixeira, A. L., et al. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.05.032 · Cited by 99 · see citing works

The interplay between BDNF and oxidative stress in chronic schizophrenia

Zhang, X. Y., Chen, D.-C., Tan, Y.-L., Tan, S.-P., Wang, Z.-R., Yang, F.-D., Okusaga, O. O., Zunta-Soares, G. B., & Soares, J. C. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.09.029 · Cited by 99 · see citing works

Role of nitric oxide and related molecules in schizophrenia pathogenesis: biochemical, genetic and clinical aspects

Nasyrova, R. F., Ivashchenko, D. V., Ivanov, M. V., & Незнанов, Н. Г. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00139 · Cited by 98 · see citing works

Sex Differences in Oxidative Stress Biomarkers

Brunelli, E., Domanico, F., Russa, D. L., & Pellegrino, D. (2014) · Current Drug Targets · doi:10.2174/1389450115666140624112317 · Cited by 95 · see citing works

Reactive Oxygen Species: The Good and the Bad

Patel, R., Rinker, L., Peng, J. Z., & Chilian, W. M. (2018) · InTech eBooks · doi:10.5772/intechopen.71547 · Cited by 93 · see citing works

Antipsychotic-induced oxidative stress in Rat Brain

Martins, M. R., Petronilho, F. C., Gomes, K. M., Dal‐Pizzol, F., STRECK, E. L., & Quevedo, J. (2008) · Neurotoxicity Research · doi:10.1007/bf03033368 · Cited by 92 · see citing works

Oxidative–antioxidative systems and their relation with serum S100 B levels in patients with schizophrenia: Effects of short term antipsychotic treatment

Sarandöl, A., Kırlı, S., Akkaya, C., Altın, A., Demirci, M., & Sarandöl, E. (2007) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.03.008 · Cited by 92 · see citing works

Basic Principles and Clinical Significance of Oxidative Stress

Gowder, S. J. T. (2015) · InTech eBooks · doi:10.5772/59293 · Cited by 89 · see citing works

The Oxidative Stress May be Induced by the Elevated Homocysteine in Schizophrenic Patients

Dietrich‐Muszalska, A., Malinowska, J., Olas, B., Głowacki, R., Bald, E., Wachowicz, B., & Rabe‐Jabłońska, J. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0707-3 · Cited by 88 · see citing works

The Dual Function of Reactive Oxygen/Nitrogen Species in Bioenergetics and Cell Death: The Role of ATP Synthase

Kaludercic, N., & Giorgio, V. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3869610 · Cited by 88 · see citing works

Antioxidant Properties of Second-Generation Antipsychotics: Focus on Microglia

Caruso, G., Grasso, M., Fidilio, A., Tascedda, F., Drago, F., & Caraci, F. (2020) · Pharmaceuticals · doi:10.3390/ph13120457 · Cited by 88 · see citing works

Advanced Oxidation Protein Products and Carbonylated Proteins as Biomarkers of Oxidative Stress in Selected Atherosclerosis-Mediated Diseases

Gryszczyńska, B., Formanowicz, D., Budzyń, M., et al. (2017) · BioMed Research International · doi:10.1155/2017/4975264 · Cited by 82 · see citing works

Interaction of oxidative stress and BDNF on executive dysfunction in patients with chronic schizophrenia

Wei, C., Sun, Y., Chen, N., Chen, S., Xiu, M., & Zhang, X. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.104473 · Cited by 78 · see citing works

Two-hit model of schizophrenia induced by neonatal immune activation and peripubertal stress in rats: Study of sex differences and brain oxidative alterations

Monte, A. S., Mello, B. S. F., Borella, V., Araújo, T. D. S., da Silva, F. E. R., de Sousa, F. C. F., de Oliveira, A. C. P., Gama, C. S., Seeman, M. V., Vasconcelos, S. M. M., et al. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.04.057 · Cited by 76 · see citing works

Decreased glutathione levels and altered antioxidant defense in an animal model of schizophrenia: Long-term effects of perinatal phencyclidine administration

Radonjić, N. V., Knežević, I. D., Vilimanovich, U., Kravić-Stevović, T., Marina, L. V., Nikolić, T., Todorović, V., Bumbaširević, V., & Petronijević, N. D. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.12.009 · Cited by 75 · see citing works

Effects of clozapine, olanzapine and haloperidol on nitric oxide production by lipopolysaccharide-activated N9 cells

Hou, Y., Wu, C. F., Yang, J., He, X., Bi, X. L., Yu, L., & Guo, T. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.05.006 · Cited by 74 · see citing works

Effects of risperidone and haloperidol on superoxide dismutase and nitric oxide in schizophrenia

Zhang, X., Zhou, D. F., Shen, Y., Zhang, P. Y., Zhang, W. F., Liang, J., Chen, D. C., Xiu, M. H., Kosten, T. A., & Kosten, T. R. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.12.014 · Cited by 74 · see citing works

Increased oxidative stress and oxidative DNA damage in non-remission schizophrenia patients

Çöpoğlu, Ü. S., Vırıt, O., Kokaçya, M. H., Örkmez, M., Bülbül, F., Erbağcı, A., Semız, M., Alpak, G., Ünal, A., Arı, M., et al. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.07.036 · Cited by 71 · see citing works

Reactive Oxygen Species (ROS) in Living Cells

(2018) · doi:10.5772/intechopen.69697 · Cited by 70 · see citing works

Oxidative mechanisms in schizophrenia and their relationship with illness subtype and symptom profile

Pazvantoğlu, O., Selek, Ş., Okay, İ. T., Şengül, C., Karabekiroğlu, K., Dılbaz, N., & Erel, Ö. (2009) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2009.02015.x · Cited by 69 · see citing works

In vitro/vivostudies towards mechanisms of risperidone-induced oxidative stress and the protective role of coenzyme Q10 and N-acetylcysteine

Eftekhari, A., Ahmadian, E., Azarmi, Y., Parvizpur, A., Hamishehkar, H., & Eghbal, M. A. (2016) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2016.1204641 · Cited by 69 · see citing works

Biomarkers of oxidative stress in schizophrenic and control subjects

Young, J. A., McKinney, S. B., Ross, B. M., Wahle, K. W. J., & Boyle, S. P. (2007) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2006.11.003 · Cited by 66 · see citing works

Potential Effect of Olanzapine on Total Antioxidant Status and Lipid Peroxidation in Schizophrenic Patients

Al-chalabi, B. M., Thanoon, I. A. J., & Ahmed, F. A. (2009) · Neuropsychobiology · doi:10.1159/000202823 · Cited by 66 · see citing works

Clozapine and olanzapine are better antioxidants than haloperidol, quetiapine, risperidone and ziprasidone in in vitro models

Brinholi, F. F., de Farias, C. C., Bonifácio, K. L., et al. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.02.047 · Cited by 66 · see citing works

A Defect in the Antioxidant Defense System in Schizophrenia

Vırıt, O., Altındağ, A., Yumru, M., Dalkiliç, A., SAVAS, H. A., Selek, Ş., Erel, Ö., & Herken, H. (2009) · Neuropsychobiology · doi:10.1159/000239684 · Cited by 63 · see citing works

Oxidative stress in bipolar and schizophrenia patients

Tunçel, Ö. K., Sarísoy, G., Bilgici, B., Pazvantoğlu, O., Çetin, E., Ünverdi, E., Avcı, B., & Böke, Ö. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.04.046 · Cited by 62 · see citing works

Imbalanced free radicals and antioxidant defense systems in schizophrenia: A comparative study

Li, H.-C., Chen, Q., Ma, Y., & Zhou, J.-F. (2006) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.2006.b0981 · Cited by 62 · see citing works

Haloperidol Cytotoxicity and Its Relation to Oxidative Stress

Raudenská, M., Gumulec, J., Babula, P., et al. (2013) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/13895575113136660100 · Cited by 60 · see citing works

Oxidative and nitrosative stress biomarkers in chronic schizophrenia

Boll, K. M., Noto, C. D. S., Bonifácio, K. L., Bortolasci, C. C., Gadelha, A., Bressan, R. A., Barbosa, D. S., Maes, M. H. J., & Moreira, E. G. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.03.038 · Cited by 60 · see citing works

First‐episode psychosis is associated with oxidative stress: Effects of short‐term antipsychotic treatment

Sarandöl, A., Sarandöl, E., Açıkgöz, E., Eker, S. S., Akkaya, C., & Dirican, M. (2015) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12333 · Cited by 59 · see citing works

Assessment of malondialdehyde levels in schizophrenia: A meta-analysis and some methodological considerations

Grignon, S., & Chianetta, J. M. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.09.012 · Cited by 59 · see citing works

Interrelationships Between BDNF, Superoxide Dismutase, and Cognitive Impairment in Drug-Naive First-Episode Patients With Schizophrenia

Xiu, M. H., Li, Z., Chen, D. C., Chen, S., Curbo, M. E., Wu, H. E., Tong, Y., Tan, S., & Zhang, X. (2020) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaa062 · Cited by 59 · see citing works

Oxidative stress in drug-naïve first episode patients with schizophrenia and major depression: effects of disease acuity and potential confounders

Jordan, W., Dobrowolny, H., Bahn, S., Bernstein, H., Brigadski, T., Frodl, T., Isermann, B., Leßmann, V., Pilz, J., Rodenbeck, A., et al. (2016) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-016-0749-7 · Cited by 58 · see citing works

Serum nitric oxide metabolite levels and the effect of antipsychotic therapy in schizophrenia

Taneli, F., Pırıldar, Ş., Akdeniz, F., Uyanık, B. S., & Arı, Z. (2004) · Archives of Medical Research · doi:10.1016/j.arcmed.2004.06.002 · Cited by 56 · see citing works

Interaction between TNF-α and oxidative stress status in first-episode drug-naïve schizophrenia

Zhu, S., Zhao, L., Fan, Y., Lv, Q., Wu, K., Lang, X., Li, Z., Yi, Z., & Geng, D. (2020) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2020.104595 · Cited by 56 · see citing works

Oxidative stress and level of antioxidant enzymes in drug-naive schizophrenics

Reyazuddin, M., Azmi, S., Islam, N., & Rizvi, A. (2014) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.146516 · Cited by 54 · see citing works

Clozapine administration reverses behavioral, neuronal, and nitric oxide disturbances in the neonatal ventral hippocampus rat

Bringas, M. E., Morales‐Medina, J. C., Flores-Vivaldo, Y., Negrete‐Díaz, J. V., Aguilar‐Alonso, P., León‐Chávez, B. A., Lazcano-Ortiz, Z., Monroy, E., Moreno, A. R., Quirion, R., et al. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.12.008 · Cited by 54 · see citing works

Antioxidant properties of atypical antipsychotic drugs used in the treatment of schizophrenia

Sadowska‐Bartosz, I., Galiniak, S., Bartosz, G., Żuberek, M., Grzelak, A., & Dietrich‐Muszalska, A. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.07.010 · Cited by 48 · see citing works

Relationship between matrix metalloproteinase-9 and oxidative stress in drug-free male schizophrenia: a case control study

Devanarayanan, S., Nandeesha, H., Kattimani, S., & Sarkar, S. (2015) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2015-0212 · Cited by 47 · see citing works

Inter-relationship of plasma markers of oxidative stress and thyroid hormones in schizophrenics

Akiibinu, M. O., Ogundahunsi, O. A., & Ogunyemi, E. O. (2012) · BMC Research Notes · doi:10.1186/1756-0500-5-169 · Cited by 45 · see citing works

The genotoxic and oxidative damage potential of olanzapine in vitro

Türkez, H., & Toğar, B. (2010) · Toxicology and Industrial Health · doi:10.1177/0748233710373090 · Cited by 41 · see citing works

Reduced total antioxidant level and increased oxidative stress in patients with deficit schizophrenia: A preliminary study

Albayrak, Y., Ünsal, C., Beyazyüz, M., Ünal, A., & Kuloğlu, M. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.04.020 · Cited by 41 · see citing works

Nitric Oxide Plasma/Serum Levels In Patients With Schizophrenia: A Systematic Review And Meta-Analysis

Maia‐de‐Oliveira, J. P., Trzesniak, C. M. F., de Oliveira, I. R., et al. (2012) · Brazilian Journal of Psychiatry · doi:10.1016/j.rbp.2012.07.001 · Cited by 40 · see citing works

Predictive value of oxidative stress biomarkers in drug‑free patients with schizophrenia and schizo-affective disorder

Guidara, W., Messedi, M., Naifar, M., Maalej, M., Grayaa, S., Omri, S., Thabet, J. B., Maalej, M. A., Charfi, N., & Ayadi, F. M. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113467 · Cited by 39 · see citing works

Prazosin, a specific alpha1-noradrenergic receptor antagonist, has no effect on symptoms but increases autonomic arousal in schizophrenic patients

Hommer, D. W., Zahn, T. P., Pickar, D., et al. (1984) · Psychiatry Research · doi:10.1016/0165-1781(84)90068-4 · Cited by 38 · see citing works

Effect of folic acid on oxidative stress and behavioral changes in the animal model of schizophrenia induced by ketamine

Zugno, A. I., Canever, L., Heylmann, A. S., Wessler, P. G., Steckert, A. V., Mastella, G. A., de Oliveira, M. B., Damázio, L. S., Pacheco, F. D., Calixto, O. P., et al. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.06.013 · Cited by 37 · see citing works

Neonatal ventral hippocampus lesion induces increase in no levels which is attenuated by subchronic haloperidol treatment

Negrete‐Díaz, J. V., Baltazar‐Gaytán, E., Bringas, M. E., Vázquez‐Roque, R. A., Newton, S., Aguilar‐Alonso, P., León‐Chávez, B. A., & Flores, G. (2010) · Synapse · doi:10.1002/syn.20835 · Cited by 30 · see citing works

Disturbed glutathione antioxidative defense is associated with structural brain changes in neuroleptic-naïve first-episode psychosis patients

Langbein, K., Hesse, J., Gussew, A., Milleit, B., Lavoie, S., Amminger, G. P., Christian Gaser, B., Wagner, G., Reichenbach, J. R., Hipler, U. ‐., et al. (2017) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2017.10.005 · Cited by 29 · see citing works

Effects of haloperidol and clozapine administration on oxidative stress in rat brain, liver and serum

Andreazza, A. C., Barakauskas, V., Fazeli, S., Feresten, A. H., Shao, L., Wei, V., Wu, C. H., Barr, A. M., & Beasley, C. L. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.02.028 · Cited by 27 · see citing works

Serum thiobarbituric acid-reactive substances and free thiol levels in schizophrenia patients: Effects of antipsychotic drugs

Huang, T., Liou, C., & Lin, T. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2009.01.017 · Cited by 27 · see citing works

Effect of atypical antipsychotics on antioxidant enzyme activities in human erythrocytes (in vitro study)

Miljević, Č., Nikolić‐Kokić, A., Nikolic, M. R., Niketić, V., Spasić, M. B., Lečić‐Toševski, D., & Blagojević, D. P. (2012) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2272 · Cited by 26 · see citing works

Evaluation of Paraoxonase, Arylesterase and Malondialdehyde Levels in Schizophrenia Patients Taking Typical, Atypical and Combined Antipsychotic Treatment

Güneş, M., Camkurt, M. A., Bulut, M., Demir, S., İbiloğlu, A. O., Kaya, M., Atlı, A., Kaplan, İ., & Sır, A. (2016) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2016.14.4.345 · Cited by 26 · see citing works

New insights on nitric oxide: Focus on animal models of schizophrenia

Morales‐Medina, J. C., Aguilar‐Alonso, P., Cerbo, A. D., Iannitti, T., & Flores, G. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113304 · Cited by 26 · see citing works

Insulin Resistance and Oxidative Stress: In Relation to Cognitive Function and Psychopathology in Drug-Naïve, First-Episode Drug-Free Schizophrenia

Tao, Q., Yu, M., Li, H., Yuan, X., Huang, X., Wang, Y., Andreassen, O. A., Fan, X., Yang, Y., & Song, X. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.537280 · Cited by 25 · see citing works

The Effects of Ziprasidone, Clozapine and Haloperidol on Lipid Peroxidation in Human Plasma (in vitro): Comparison

Dietrich‐Muszalska, A., Kopka, J., & Kwiatkowska, A. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1050-z · Cited by 23 · see citing works

Oxidative metabolism may be associated with negative symptoms in schizophrenia

Güneş, M., Altındağ, A., Bulut, M., Demir, S., İbiloğlu, A. O., Kaya, M., Atlı, A., & Aksoy, N. (2017) · Psychiatry and Clinical Psychopharmacology · doi:10.1080/24750573.2017.1293243 · Cited by 22 · see citing works

Nitric oxide, asymmetric dimethylarginine, symmetric dimethylarginine and L-arginine levels in psychotic exacerbation of schizophrenia and bipolar disorder manic episode

Üstündağ, M. F., Özcan, H., Gençer, A. G., et al. (2020) · Saudi Medical Journal · doi:10.15537/smj.2020.1.24817 · Cited by 21 · see citing works

Reduced serum paraoxonase 1 (PON1) activity in patients with schizophrenia treated with olanzapine but not quetiapine

Albayrak, Y., Ünsal, C., Albayrak, N., Kuloğlu, M., & Hashimoto, K. (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s52463 · Cited by 20 · see citing works

Isoprenoid pathway and free radical generation and damage in neuropsychiatric disorders.

Ravikumar, A., Arun, P., Devi, K. V. D., Augustine, J., & Kurup, P. A. (2000) · PubMed · Cited by 19 · see citing works

Mechanism of inhibition of tumor necrosis factor production by chlorpromazine and its derivatives in mice

Ghezzi, P., Garattini, S. K., Mennini, T., et al. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00728-5 · Cited by 17 · see citing works

Status of plasma nitric oxide and non-enzymatic antioxidants before and after antipsychotic treatment in Nigerian patients with schizophrenia.

Arinola, O., & Idonije, O. B. (2009) · PubMed · Cited by 16 · see citing works

The effect of acute aripiprazole treatment on chemically and electrically induced seizures in mice: The role of nitric oxide

Shafaroodi, H., Oveisi, S., Hosseini, M., Niknahad, H., & Moezi, L. (2015) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2015.05.018 · Cited by 16 · see citing works

Increased Oxidant Stress and Inflammation in Patients with Chronic Schizophrenia

Yeĝin, A., Ay, N., Aydın, Ö., Yargici, N., Eren, E., & Yılmaz, N. (2012) · International Journal of Clinical Medicine · doi:10.4236/ijcm.2012.35070 · Cited by 15 · see citing works

The Relationship between the Level of Anterior Cingulate Cortex Metabolites, Brain-Periphery Redox Imbalance, and the Clinical State of Patients with Schizophrenia and Personality Disorders

Bryll, A., Krzyściak, W., Karcz, P., Śmierciak, N., Kozicz, T., Skrzypek, J., Szwajca, M., Pilecki, M. W., & Popiela, T. J. (2020) · Biomolecules · doi:10.3390/biom10091272 · Cited by 15 · see citing works

Transition Metals and Other Forms of Oxidative Protein Damage in Renal Disease

Monnier, V. M., Nemet, I., Sell, D. R., & Weiss, M. F. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-857-7_2 · Cited by 11 · see citing works

Comparison of the antioxidant potential of antiparkinsonian drugs in different in vitro models

de Farias, C. C., Bonifácio, K. L., Matsumoto, A. K., et al. (2014) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s1984-82502014000400017 · Cited by 11 · see citing works

Generalized estimating equation model and long-term exposure effect of antipsychotics on SH-SY5Y cells against oxidative stressors

Yang, M., Chen, K., & Lung, F. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.06.007 · Cited by 11 · see citing works

Thiol Disulfide Homeostasis in Schizophrenic Patients Using Atypical Antipsychotic Drugs

Doğan, H. O., Erşan, E. E., Aydın, H., Erdoğan, S., Erşan, S., Alışık, M., Bakır, S., Erel, Ö., & Koç, D. (2018) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2018.16.1.39 · Cited by 11 · see citing works

Oxidative stress markers in schizophrenic patients

Mabrouk, H., Houas, I., Mechria, H., Mechri, A., Douki, W., Gaha, L., & Najjar, M. F. (2012) · Immuno-analyse & Biologie Spécialisée · doi:10.1016/j.immbio.2012.10.005 · Cited by 10 · see citing works

Evaluation of lipid peroxidation in red blood cells by monitoring the uptake of sucrose and phenol red

Sawas, A. H., & Pentyala, S. (2004) · Journal of Applied Toxicology · doi:10.1002/jat.976 · Cited by 9 · see citing works

Associations of oxidative stress status parameters with traditional cardiovascular disease risk factors in patients with schizophrenia

Vidović, B. B., Stefanović, A., Milovanović, S., Đorđević, B., Kotur‐Stevuljević, J., Ivanišević, J., Miljković, M., & Spasić, S. (2014) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2013.873947 · Cited by 7 · see citing works

Lipid Peroxidation and Antioxidant Status in Schizophrenic Patients Treated by Quetiapine

Thanoon, I. A. J., Hasan, M. S., & Ahmed, F. A. (2014) · Jordan Medical Journal · Cited by 1 · see citing works

Lipid Peroxidation and Antioxidant Status in Schizophrenic Patients Treated by Quetiapine = زناخة الدهون و مضادات الأكسدة الكلي في المرضى المصابين بالانفصام و تحت علاج عقار كيوتابين

Ahmed, F. A., Hasan, M. S., & Thanoon, I. A. J. (2014) · Jordan Medical Journal · doi:10.12816/0025873 · Cited by 1 · see citing works

Lipids in Psychiatric Disorders: Functional and Potential Diagnostic Role as Blood Biomarkers

Zorkina, Y., Ushakova, V., Ochneva, A., Tsurina, A., Abramova, O., Savenkova, V., Goncharova, A., Alekseenko, I., Morozova, I., Riabinina, D., et al. (2024) · Metabolites · doi:10.3390/metabo14020080 · Cited by 36 · see citing works

Representing Carbonyl Stress: A New Application of TBARS

Guo, L. (2003) · Jiguang shengwu xuebao

The biological significance of malondialdehyde determination in the assessment of tissue oxidative stress

Valenzuela, A. (1991) · Life Sciences · doi:10.1016/0024-3205(91)90550-u · Cited by 291 · see citing works

Melanomas suppress lipid peroxidation in host mice

Borovanský, J., Crkovska, J., Schwippelová, Z., et al. (2013) · Oxidants and Antioxidants in Medical Science · doi:10.5455/oams.270313.or.032

[Evaluation of lipid peroxidation by measuring thiobarbituric acid reactive substances].

Lefèvre, G., Beljean-Leymarie, M., Beyerle, F., et al. (1998) · PubMed · Cited by 153 · see citing works

Oxidative stress in HIV positive children

Dias, B. F., & Srinivas, A. (2017) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20171268